We are live on ! Find out more
PA

Pinnacle Associates Portfolio holdings

AUM $7.78B
1-Year Est. Return 45.07%
This Fund
S&P 500
This Quarter Est. Return
+14.33%
1 Year Est. Return
+45.07%
3 Year Est. Return
+102.47%
5 Year Est. Return
+115.95%
10 Year Est. Return
+586.2%
AUM
$6.91B
AUM Growth
+$82.5M
Cap. Flow
-$567M
Cap. Flow %
-8.2%
Top 10 Hldgs %
24.12%
Holding
865
New
42
Increased
270
Reduced
470
Closed
20

Top Buys

Rank Stock Value
1
VTI icon
Vanguard Total Stock Market ETF
VTI
+$34.6M
2
WMT icon
Walmart Inc
WMT
+$12.2M
3
NVDA icon
NVIDIA
NVDA
+$8.11M
4
EOLS icon
Evolus
EOLS
+$7.02M
5
ABBV icon
AbbVie
ABBV
+$6.93M

Sector Composition

Rank Sector Weight
1 Technology 23.46%
2 Financials 11.35%
3 Healthcare 9.92%
4 Industrials 8.66%
5 Communication Services 7.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRP icon
526
Invesco Variable Rate Preferred ETF
VRP
$2.98B
$896K 0.01%
36,652
-950
-3% -$22.9K
VIS icon
527
Vanguard Industrials ETF
VIS
$7.94B
$893K 0.01%
3,189
APH icon
528
Amphenol
APH
$185B
$887K 0.01%
8,985
+582
+7% +$47.6K
GSK icon
529
GSK
GSK
$106B
$887K 0.01%
23,103
-2,306
-9% -$88.1K
KEYS icon
530
Keysight
KEYS
$50.4B
$887K 0.01%
5,410
+51
+1% +$7.77K
JPST icon
531
JPMorgan Ultra-Short Income ETF
JPST
$40.1B
$886K 0.01%
17,477
-338
-2% -$17.1K
CFG icon
532
Citizens Financial Group
CFG
$30.5B
$883K 0.01%
19,735
+8,693
+79% +$342K
FYBR
533
DELISTED
Frontier Communications
FYBR
$881K 0.01%
24,215
-1,460
-6% -$53K
THRY icon
534
Thryv Holdings
THRY
$183M
$881K 0.01%
72,431
+15,975
+28% +$206K
BSX icon
535
Boston Scientific
BSX
$69.3B
$869K 0.01%
8,088
+404
+5% +$40.9K
ACWX icon
536
iShares MSCI ACWI ex US ETF
ACWX
$11.1B
$864K 0.01%
14,170
GXO icon
537
GXO Logistics
GXO
$5.89B
$860K 0.01%
17,665
-765
-4% -$30.5K
SPG icon
538
Simon Property Group
SPG
$76.7B
$857K 0.01%
5,330
+649
+14% +$103K
FBT icon
539
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.84B
$849K 0.01%
5,260
-243
-4% -$38.7K
ILCG icon
540
iShares Morningstar Growth ETF
ILCG
$3B
$837K 0.01%
8,641
-117
-1% -$10.2K
COR icon
541
Cencora
COR
$62.4B
$833K 0.01%
2,777
-40
-1% -$11.5K
NEM icon
542
Newmont
NEM
$93.9B
$830K 0.01%
14,243
-1,741
-11% -$92.9K
REVG
543
DELISTED
REV Group
REVG
$826K 0.01%
17,352
-17,293
-50% -$643K
AIOT
544
PowerFleet Inc
AIOT
$521M
$819K 0.01%
190,053
-4,616
-2% -$22.8K
UAL icon
545
United Airlines
UAL
$39.2B
$819K 0.01%
10,286
+116
+1% +$8.55K
BOND icon
546
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.39B
$811K 0.01%
8,801
-1,186
-12% -$108K
LOB icon
547
Live Oak Bancshares
LOB
$1.97B
$806K 0.01%
27,059
+5,575
+26% +$150K
SBSI icon
548
Southside Bancshares
SBSI
$968M
$789K 0.01%
+26,804
New +$760K
PPL
549
PPL Corp
PPL
$27.4B
$786K 0.01%
23,184
+59
+0.3% +$2.05K
BCAL icon
550
Southern California Bancorp
BCAL
$692M
$781K 0.01%
+49,574
New +$707K

Similar funds

Pinnacle Associates's Q2 2025 Portfolio in Review

As of Q2 2025, Pinnacle Associates held 865 positions worth $6.91B, up 1.2% from $6.82B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Pinnacle Associates withdrew a net $567M in Q2 2025, closing 20 positions and reducing 470 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $17.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Pinnacle Associates opened a new position in Evolus worth $6.32M.

  • Pinnacle Associates's largest Q2 2025 buy was Evolus: 685,960 shares worth $6.32M.
  • Pinnacle Associates added most to Vanguard Total Stock Market ETF in Q2 2025, an estimated $34.6M increase.
  • Pinnacle Associates's biggest Q2 2025 reduction was Johnson & Johnson, cutting an estimated $335M.
  • Pinnacle Associates fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $17.9M.
  • Pinnacle Associates's ten largest holdings make up 24% of its $6.91B portfolio in Q2 2025.
  • Pinnacle Associates opened 42 new positions and closed 20 in Q2 2025.
  • Pinnacle Associates's portfolio value rose 1.2% quarter-over-quarter to $6.91B.

Based on Pinnacle Associates's 13F filing for Q2 2025, filed 4 Aug 2025.